
FranziskaHausmann
@franziskahauth
resident radiation oncology and clinician scientist #RadOnc #womeninRadonc, views=my own
ID: 1336793789709619203
09-12-2020 22:04:21
62 Tweet
47 Followers
81 Following

A few years ago we started ctRO as a new ESTRO journal. Today we received our first impact factor: 4.7 ! Thanks to all authors, reviewers and readers for making this such a big success. And most imporantly to Pierre Blanchard, MD and Daniel Zips for leading this project! #radonc


Are you Interested in spending 1 year in #Germany to conduct your own research? 🤓Apply now for the German Chancellor Fellowship by Humboldt-Stiftung! Deadline is 📅 15 October! buff.ly/3NubVBT





🚨 Our latest paper on online-MR guided response adaptive RT in rectal cancer. 👉 ⬆️response with 5/5 with sustained cCR 👉 Acute toxicity ⬇️ 👉 Excellent organ function DFG public | @[email protected] Uniklinikum Tübingen #radonc bit.ly/3yI9RSi


@BetterCallBenni Cihan Gani Pierre Blanchard, MD Simon Boeke @cd_fuller @DeniseB50976534 Deutsche Gesellschaft für Radioonkologie e.V. ASTRO Angel Degro Actually the Task Force „Teaching“ Angel Degro has published a comprehensive report on the upcoming reform of the medical curriculum with detailed reommendations on how to implement #radonc teaching bit.ly/DEGRO-teaching @Mike_Oertel_MD Prof. Dr. Stephanie Combs LMU Radiation Oncology








Headline of The New York Times copy-pasted by The Telegraph "Thousands of bowel cancer pts can be spared brutal radiotherapy, study finds" telegraph.co.uk/news/2023/06/0… 👉 High-quality PROSPECT deserves high-quality & balanced news coverage 👉 Scientific community needs to stand up, together!





Der Vorstand der #CharitéBerlin hat heute gemeinsam mit Senatorin Ina Czyborra Senatsverwaltung WGP ein neues, KI-gestütztes Hightech-Gerät zur adaptiven #Strahlentherapie eingeweiht. Damit können Krebspatient:innen noch gezielter und schonender behandelt werden. charite.de/service/presse…


Why publish in Clinical & Translational Radiation Oncology? 🔹ctRO is part of ESTRO 🔹Editorial board with international experts 🔹Open access ensures high visibility for your research 🔹Robust review process 🔹No spam emails 😉 Submit your next paper to ctRO! #radonc #medtwitter #openaccess
